BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 24799564)

  • 1. Activation of the STING adaptor attenuates experimental autoimmune encephalitis.
    Lemos H; Huang L; Chandler PR; Mohamed E; Souza GR; Li L; Pacholczyk G; Barber GN; Hayakawa Y; Munn DH; Mellor AL
    J Immunol; 2014 Jun; 192(12):5571-8. PubMed ID: 24799564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-treatments to Boost IDO Activity and Inhibit Production of Downstream Catabolites Induce Durable Suppression of Experimental Autoimmune Encephalomyelitis.
    Lemos H; Mohamed E; Ou R; McCardle C; Zheng X; McGuire K; Homer NZM; Mole DJ; Huang L; Mellor AL
    Front Immunol; 2020; 11():1256. PubMed ID: 32625215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutting edge: DNA sensing via the STING adaptor in myeloid dendritic cells induces potent tolerogenic responses.
    Huang L; Li L; Lemos H; Chandler PR; Pacholczyk G; Baban B; Barber GN; Hayakawa Y; McGaha TL; Ravishankar B; Munn DH; Mellor AL
    J Immunol; 2013 Oct; 191(7):3509-13. PubMed ID: 23986532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulator of interferon genes agonists attenuate type I diabetes progression in NOD mice.
    Lemos H; Mohamed E; Huang L; Chandler PR; Ou R; Pacholczyk R; Mellor AL
    Immunology; 2019 Dec; 158(4):353-361. PubMed ID: 31557322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytosolic DNA sensing via the stimulator of interferon genes adaptor: Yin and Yang of immune responses to DNA.
    Lemos H; Huang L; McGaha TL; Mellor AL
    Eur J Immunol; 2014 Oct; 44(10):2847-53. PubMed ID: 25143264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation.
    Lemos H; Mohamed E; Huang L; Ou R; Pacholczyk G; Arbab AS; Munn D; Mellor AL
    Cancer Res; 2016 Apr; 76(8):2076-81. PubMed ID: 26964621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering DNA nanoparticles as immunomodulatory reagents that activate regulatory T cells.
    Huang L; Lemos HP; Li L; Li M; Chandler PR; Baban B; McGaha TL; Ravishankar B; Lee JR; Munn DH; Mellor AL
    J Immunol; 2012 May; 188(10):4913-20. PubMed ID: 22516958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of IFN-gamma enables the expansion of autoreactive CD4+ T cells to induce experimental autoimmune encephalomyelitis by a nonencephalitogenic myelin variant antigen.
    Sabatino JJ; Shires J; Altman JD; Ford ML; Evavold BD
    J Immunol; 2008 Apr; 180(7):4451-7. PubMed ID: 18354166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active immunization using a single dose immunotherapeutic abates established EAE via IL-10 and regulatory T cells.
    Rynda-Apple A; Huarte E; Maddaloni M; Callis G; Skyberg JA; Pascual DW
    Eur J Immunol; 2011 Feb; 41(2):313-23. PubMed ID: 21268002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bee Venom Acupuncture Alleviates Experimental Autoimmune Encephalomyelitis by Upregulating Regulatory T Cells and Suppressing Th1 and Th17 Responses.
    Lee MJ; Jang M; Choi J; Lee G; Min HJ; Chung WS; Kim JI; Jee Y; Chae Y; Kim SH; Lee SJ; Cho IH
    Mol Neurobiol; 2016 Apr; 53(3):1419-1445. PubMed ID: 25579380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STING Agonist Mitigates Experimental Autoimmune Encephalomyelitis by Stimulating Type I IFN-Dependent and -Independent Immune-Regulatory Pathways.
    Johnson BM; Uchimura T; Gallovic MD; Thamilarasan M; Chou WC; Gibson SA; Deng M; Tam JW; Batty CJ; Williams J; Matsushima GK; Bachelder EM; Ainslie KM; Markovic-Plese S; Ting JP
    J Immunol; 2021 May; 206(9):2015-2028. PubMed ID: 33820855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis.
    Willenborg DO; Fordham S; Bernard CC; Cowden WB; Ramshaw IA
    J Immunol; 1996 Oct; 157(8):3223-7. PubMed ID: 8871615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-γ ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation.
    Sosa RA; Murphey C; Robinson RR; Forsthuber TG
    Proc Natl Acad Sci U S A; 2015 Sep; 112(36):E5038-47. PubMed ID: 26305941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel CD8+ Treg suppress EAE by TGF-beta- and IFN-gamma-dependent mechanisms.
    Chen ML; Yan BS; Kozoriz D; Weiner HL
    Eur J Immunol; 2009 Dec; 39(12):3423-35. PubMed ID: 19768696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAIL-Mediated Suppression of T Cell Receptor Signaling Inhibits T Cell Activation and Inflammation in Experimental Autoimmune Encephalomyelitis.
    Chyuan IT; Tsai HF; Wu CS; Sung CC; Hsu PN
    Front Immunol; 2018; 9():15. PubMed ID: 29403497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice.
    Vandenbark AA; Rich C; Mooney J; Zamora A; Wang C; Huan J; Fugger L; Offner H; Jones R; Burrows GG
    J Immunol; 2003 Jul; 171(1):127-33. PubMed ID: 12816990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EAE mediated by a non-IFN-γ/non-IL-17 pathway.
    Kroenke MA; Chensue SW; Segal BM
    Eur J Immunol; 2010 Aug; 40(8):2340-8. PubMed ID: 20540117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin enhances endogenous haem oxygenase-1 and represses immune responses to ameliorate experimental autoimmune encephalomyelitis.
    Chen SJ; Wang YL; Lo WT; Wu CC; Hsieh CW; Huang CF; Lan YH; Wang CC; Chang DM; Sytwu HK
    Clin Exp Immunol; 2010 Nov; 162(2):210-23. PubMed ID: 21069936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Experimental Autoimmune Encephalomyelitis by Sustained Delivery of Low-Dose IFN-α.
    Vasquez M; Consuegra-Fernández M; Aranda F; Jimenez A; Tenesaca S; Fernandez-Sendin M; Gomar C; Ardaiz N; Di Trani CA; Casares N; Lasarte JJ; Lozano F; Berraondo P
    J Immunol; 2019 Aug; 203(3):696-704. PubMed ID: 31209101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerogen-induced interferon-producing killer dendritic cells (IKDCs) protect against EAE.
    Huarte E; Rynda-Apple A; Riccardi C; Skyberg JA; Golden S; Rollins MF; Ramstead AG; Jackiw LO; Maddaloni M; Pascual DW
    J Autoimmun; 2011 Dec; 37(4):328-41. PubMed ID: 22018711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.